慧甚 FDS 深 滬
等待開盤 10-09 09:30:00 美东时间
286.52
+13.740
+5.04%
華盛通- 最 高288.445
- 今 開273.48
- 成交量 112.86万股
- 最 低 273.125
- 昨 收 272.78
- 總市值 101.90亿
- 52周最高 320.48
- 市盈率 靜 19.67
- 換手率 3.17%
- 52周最低 181.58
- 委 比 -25.00%
- 總股本 3556.55万
- 歷史最高 491.07
- 量 比 1.50
- 振 幅 5.62%
- 歷史最低 40.19
- 每 手 1
- 風險率 32.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多S&P 500 Index Nears Record High as Wall Street Braces for Strong Earnings Season
The S&P 500 Index has wavered and is hovering near its all-time high. The next few weeks could be important as top companies report earnings and the odds of a Federal Reserve rate hike decline. The index ended the week at 7,722 points, slightly below its record of 7,817. Wall Street Analysts Are Bra...
10-04 01:30
电话会总结 ｜ FactSet(FDS)2026财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• # FactSet 2026财年第四季度及全年业绩回顾摘要 ## 1. 财务业绩 **第四季度业绩（FY2026 Q4）：** - **营收（Revenue）**：6.347亿美元，报告口径同比增长6.3%，有机增长7.1%，由广泛的需求驱动 - **调整后营业利润（Adjusted Operating Income）**：2.09亿美元，调整后营业利润率为33% - **调整后摊薄每股收益（Adjusted Diluted EPS, non-GAAP）**：4.52美元，同比增长11.6% - **有机ASV（年度订阅价值）增量**：8600万美元
10-02 12:32
美股大行评级 | 潜在涨幅1654.39%！Ascendiant Capital上调NRX Pharmaceuticals(NRXP)目标价至50美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从49美元升至50美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从24美元升至25美元
10-02 08:33
FactSet Research Analysts Boost Their Forecasts After Upbeat Q4 Results
FactSet Research Systems Inc. (NYSE:FDS) on Wednesday posted upbeat earnings for the fourth quarter and issued weaker-than-expected fiscal 2027 guidance. FactSet reported adjusted earnings of $4.52 per share, beating the analyst consensus estimate of $4.33. Revenue rose 6.3% year over year to $634.7...
10-02 02:27
Stifel Maintains Hold on FactSet Research Systems, Raises Price Target to $292
Stifel analyst Shlomo Rosenbaum maintains FactSet Research Systems (NYSE:FDS) with a Hold and raises the price target from $254 to $292.
10-01 20:04
FactSet Calls 2026 Margins the ‘Floor’ As It Targets Profitability Improvement
FactSet Research Systems Inc. (NYSE:FDS) stock gained nearly 3% Wednesday after the financial data provider reported better-than-expected fourth-quarter earnings and revenue. The company reported better-than-expected fiscal 2026 fourth-quarter results, although its fiscal 2027 guidance came in below...
10-01 02:17
Earnings Scheduled For September 30, 2026
Companies Reporting Before The Bell • FactSet Research Systems (NYSE:FDS) is expected to report quarterly earnings at $4.34 per share on revenue of $629.46 million. • Cal-Maine Foods (NASDAQ:CALM) is projected to report quarterly loss at $0.59 per share on revenue of $574.81 million. • Yiren Digital...
09-30 19:11
FactSet Research Systems Sees FY2027 GAAP EPS $17.00-$17.50 vs $17.85 Est
FactSet Research Systems (NYSE:FDS) is looking for FY2027 GAAP EPS of $17.00-$17.50 vs $17.85 analyst estimate..
09-30 19:01
FactSet Research Systems Sees FY2027 Adj EPS $19.25-$19.65 vs $19.68 Est; Sees Sales $2.600B-$2.625B vs $2.616B Est
FactSet Research Systems (NYSE:FDS) is looking for FY2027 Adj EPS of $19.25-$19.65 vs $19.68 analyst estimate. sees sales of $2.600 billion-$2.625 billion vs $2.616 billion analyst estimate.
09-30 19:00
FactSet Research Systems Q4 Adj. EPS $4.52 Beats $4.33 Estimate, Sales $634.698M Beat $629.829M Estimate
FactSet Research Systems (NYSE:FDS) reported quarterly earnings of $4.52 per share which beat the analyst consensus estimate of $4.33 by 4.15 percent. This is a 11.6 percent increase over earnings of $4.05 per share from the same period last year. The company reported quarterly sales of $634.698 mil...
09-30 19:00
